FACTORS GOVERNING THE MODULATION OF VINCA-ALKALOID RESISTANCE IN DOXORUBICIN-RESISTANT CELLS BY THE CALMODULIN INHIBITOR TRIFLUOPERAZINE

被引：26

作者：

GANAPATHI, R

GRABOWSKI, D

SCHMIDT, H

机构：

来源：

关键词：

D O I：

10.1016/0006-2952(86)90366-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：673 / 678

页数：6

共 27 条

[1] CELLULAR PHARMACOLOGY OF VINCA ALKALOID RESISTANCE AND ITS CIRCUMVENTION
BECK, WT
[J]. ADVANCES IN ENZYME REGULATION, 1984, 22 : 207 - 227
[2] BENDER RA, 1982, PHARM PRINCIPLES CAN, P256
[3] Creasey WA, 1981, CANCER CHEMOTHERAPY, V3, P79
[4] DANO K, 1972, CANCER CHEMOTH REP 1, V56, P701
[5] DANO K, 1976, ACTA PATHOL MICRA SN, V256, P11
[6] FERGUSON PJ, 1984, CANCER RES, V44, P3307
[7] CORRELATION BETWEEN POTENCY OF CALMODULIN INHIBITORS AND EFFECTS ON CELLULAR-LEVELS AND CYTO-TOXIC ACTIVITY OF DOXORUBICIN (ADRIAMYCIN) IN RESISTANT P388 MOUSE LEUKEMIA-CELLS
GANAPATHI, R
GRABOWSKI, D
TURINIC, R
VALENZUELA, R
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (06): : 799 - 806
[8] GANAPATHI R, 1983, CANCER RES, V43, P3696
[9] GANAPATHI R, 1984, CANCER RES, V44, P5056
[10] GANAPATHI R, 1982, J NATL CANCER I, V68, P1027